药物对比
Linagliptin vs Glyburide
比较 Linagliptin（DPP-4）与 Glyburide（磺脲类）治疗2型糖尿病：疗效、低血糖风险、体重影响和肾脏安全性。
此页面暂无可用的对比维度。
临床背景
This comparison arises when selecting between a DPP-4 inhibitor and a sulfonylurea for type 2 diabetes, particularly in patients at elevated hypoglycemia or renal risk.
结论
Linagliptin typically offers a more favorable safety profile than Glyburide for most type 2 diabetes patients.
全部药物对比